Product Information
TEMAZEPAM 7.5 MG CAPSULE is a generic product labeled by SpecGx LLC, priced at $0.9537 per EA under NDC 00406996001. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the temazepam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
7.5 mg/1
Manufacturer
SpecGx LLCNDC
00406996001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TEMAZEPAMApproval Type
New Drug (NDA)
FDA Application
NDA018163FDA Approved
Before 1982
TE Code
AB
On Market Since
2/23/2010
Pharmacological Classes
Price Statistics
The NADAC for TEMAZEPAM 7.5 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 78.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9537 per EA |
|---|---|
| All-time high | $5.1228 (Sep 10, 2014) |
| All-time low | $0.7393 (Nov 20, 2024) |
| 52-week high | $0.9537 |
| 52-week low | $0.7894 |
| Median price | $1.7309 |
| Average price | $2.2418 |
| Largest weekly change | +51.7% (Aug 21, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TEMAZEPAM 7.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 7.5 MG CAPSULE, manufactured by SpecGx LLC, is $0.9537 per EA (NDC 00406996001), effective Aug 19, 2026.
How has the price of TEMAZEPAM 7.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMAZEPAM 7.5 MG CAPSULE has declined 78.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TEMAZEPAM 7.5 MG CAPSULE?
Since Nov 28, 2013, the NADAC for TEMAZEPAM 7.5 MG CAPSULE has ranged from a low of $0.7393 (Nov 20, 2024) to a high of $5.1228 (Sep 10, 2014), with a median of $1.7309 per EA.
Are there cheaper alternatives to TEMAZEPAM 7.5 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TEMAZEPAM 7.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TEMAZEPAM 7.5 MG CAPSULE?
TEMAZEPAM 7.5 MG CAPSULE (NDC 00406996001) is labeled by SpecGx LLC, and CMS classifies it as a generic product.